News
Claims That the FDA Has Approved Ivermectin to Treat COVID-19 Are False
At the peak of the COVID-19 pandemic, many vaccine skeptics turned to ivermectin, a medication proven to fight off parasitic diseases, to offer protection against the virus. As The Dispatch Fact Check reported repeatedly at the time, ivermectin has not been proven effective at either slowing the spread of COVID-19 or alleviating its symptoms.
Health system pharmacists and physicians are monitoring a wave of expected new drug approvals between late 2024 and third quarter of 2025. A recent article published in the American Journal of ...
Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...
A new drug that reduces the risk of breast cancer recurrence has been approved in England. According to an analysis by the ...
Asking your specialist is another good idea. Your cardiologist knows you, and although they might not know every new drug, ...
On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...
Lupin gains US FDA approval for Tolvaptan tablets in various dosages, marking a significant entry into the nephrology market.
In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This ...
Trastuzumab deruxtecan approved to treat adults with HER2-positive cancer that’s spread or can’t be removed by surgery.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback